Search This Blog

Wednesday, January 8, 2020

Globus Medical sees Q4 sales of $211M

On a preliminary basis, Globus Medical (NYSE:GMED) expects Q4 and 2019 sales to be ~$211.0M (+8%) and ~$784.7M (+10%), respectively.
2020 guidance: Sales: $850M; non-GAAP EPS: $1.82.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)